What this means
This is a plan for a study that will follow older patients who have ERCP, a test and treatment for bile duct and pancreas problems. It will look at factors linked to problems and longer hospital stays.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65 and over
- Where
- 5 sites
The science
- Registered title
- Factors for Prolonged Hospital Stays in Patients Undergoing ERCP
- Trial ID
- NCT07568626 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Post-ERCP Adverse Events, ERCP Complications
- Sponsor
- Air Force Military Medical University, China
- Ages
- 65 Years to no maximum
- Dates
- First posted May 6, 2026 · updated Jul 14, 2026
Registry summary
Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial minimally invasive technique for the diagnosis and treatment of biliary and pancreatic diseases. However, it remains technically demanding and carries a postoperative adverse event (AE) rate exceeding 10% (e.g., pancreatitis, bleeding, and perforation), which subsequently leads to prolonged length of stay (LOS) and increased healthcare costs. With the rapid acceleration of population aging, the clinical demand for ERCP among the elderly has surged. Although ERCP is generally considered safe for older adults, advanced age also increases the risk of ERCP-related AEs and prolonged LOS. While previous studies investigated the outcomes of ERCP in elderly patients, those studies were predominantly retrospective, accompanied by selection bias. Moreover, insufficient factors were included in those retrospective studies. Importantly, some aging-related parameters, such as frailty, functional reserve, cognitive and psychological status, were not included in previous studies. Therefore, the investigators conducted a prospective, multicenter cohort study aimed at investigating outcomes in elderly patients undergoing ERCP and comprehensive factors (patient-related, procedure-related, and geriatric factors) associated with adverse outcomes.
Sites (5)
- Xiamen Hong'ai Hospital, Xiamen, Fujian, China
- Xijing Hospital of Digestive Diseases, Xi'an, Shaanxi, China
- The Second Affiliated Hospital of Air Force Military Medical University, Xi'an, Shaanxi, China
- Department of Gastroenterology, 986 Hospital of Xijing Hospital, Fourth MilitaryMedical University, Xi'an, Shaanxi, China
- Xi'an Honghui Hospital, Xi'an, Shaanxi, China
